Viyash Scientific Ltd.

₹271.4

16.4 (6.5%)

VIYASH Share Price

Pharmaceuticals & Biotechnology

As on August 19, 2026

SectorHealthcare

IndustryPharmaceuticals & Biotechnology

Basic IndustryPharmaceuticals

Market Cap₹ 11,205 Cr

P/E Ratio156.27

Dividend YieldN/A

Trendline Performance

We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.

Unlock Stock of the Month

T&C*

Technicals

Indicators	Value	Signal
5-DMA	260.09	Bullish
10-DMA	264.79	Bullish
20-DMA	261.49	Bullish
50-DMA	266.1	Bullish
100-DMA	243.37	Bullish
200-DMA	226.9	Bullish

Historical Performance

1 Year

54%

3 Years

209.1%

5 Years

12.8%

10 Years

126.2%

Shareholding Pattern

Values Analysis

Loading chart...

Profit & Loss

Below figures are in Rs. Crores

Particulars	Mar-2026	Mar-2025	Mar-2024	Mar-2023	Mar-2022
Net Sales	34,203	30,068	13,697	14,209	14,128
Total Expenditure	27,678	26,228	13,083	14,090	13,034
Other Income	436	358	110	64	109
Operating Profit	6,961	4,198	724	183	1,202
Interest	692	864	481	355	158
Depreciation	2,336	2,387	615	557	515
Profit Before Tax	3,490	132	-546	-1,377	529
Consolidated Net Profit	1,773	232	-359	-1,212	410
Adjusted EPS	4	1	-1	-5	2

Compounded Sales Growth

10 Years:28.5

5 Years:39.1

3 Years:44.1

TTM:1.1

Compounded Profit Growth

10 Years:48.8

5 Years:18.8

3 Years:34

TTM:5.3

Stock Price CAGR

10 Years:8.5

5 Years:2

3 Years:45.7

TTM:53.3

Return on Equity

10 Years:-0.6

5 Years:0.6

3 Years:0

last year:1.7

Quarterly Results

Below figures are in Rs. Crores

Particulars	Sep-2024	Dec-2024	Mar-2025	Jul-2025	Sep-2025
Sales	1,70,754	1,35,936	1,28,552	1,22,189	1,05,161
Expenses	63,042	56,557	52,457	45,459	34,856
Operating Profit	1,07,712	79,379	76,096	76,730	70,304
OPM %	63%	58%	59%	63%	67%
Other Income	33,912	31,759	27,333	24,879	18,947
Interest	77,780	58,584	59,248	62,137	53,713
Depreciation	2,345	1,681	1,385	1,277	1,221
Profit Before Tax	61,498	50,873	42,796	38,195	34,318
Tax %	25%	25%	26%	29%	35%
Net Profit	46,149	38,151	31,857	27,296	22,446
EPS in Rs	83	69	58	50	42

Balance Sheet

Below figures are in Rs. Crores

Particulars	Mar-2026	Mar-2025	Mar-2024	Mar-2023	Mar-2022
Share Capital	874	501	499	499	497
Total Reserves	26,178	22,016	5,294	5,926	5,953
Long-Term Borrowings	---	---	---	---	---
Total Non-Current Liabilities	4,844	4,398	1,726	1,758	2,091
Other Current Liabilities	1,873	2,864	1,186	1,096	790
Short Term Borrowings	1,215	2,042	2,459	1,821	1,595
Total Liabilities	45,450	40,198	15,311	14,838	14,866
Capital Work in Progress	687	428	111	514	88
Long Term Loans & Advances	322	406	695	217	540
Currents Investments	---	1	26	---	14
Short Term Loans and Advances	1,179	1,051	648	432	628
Total Current Assets	22,546	17,828	8,295	7,798	8,084
Total Assets	45,450	40,198	15,311	14,838	14,866
Adjusted Book Value	62	90	23	26	26

Positive

(80 to 100)

Neutral

(60 to 79)

Negative

(0 to 59)

The stock has a high PE of 156.27, indicating expensive valuation or elevated growth expectations.
Over the last three years, the stock delivered a strong 3-year price CAGR of 45.2%, indicating sustained price appreciation.
The stock carries a high beta of 1.4, implying higher volatility and elevated risk.
In the last financial year, the company reported an EBITDA of ₹3008 million, reflecting positive operating performance.
In the previous financial year, the company generated revenue of ₹13821 million, indicating a large and established business.

Investment Calculator

Investment Amount:₹

Investment Amount: ₹ 1000000

Current Value: ₹ 1532986.9

No. of Shares: 5648 (Approx)

Performance:53.3%

532986.9

NIFTY Performance: -3.9%

1 day Top Gainers